Tissue Repair Ltd (ASX:TRP)
0.2200
0.00 (0.00%)
Apr 24, 2025, 4:10 PM AEST
Tissue Repair Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Operating Revenue | 0.29 | 0.15 | 0 | - | - | 0 |
Other Revenue | 2.1 | 1.64 | 0.97 | 0.17 | 0.15 | - |
Revenue | 2.39 | 1.79 | 0.97 | 0.17 | 0.15 | 0 |
Revenue Growth (YoY) | 131.65% | 84.31% | 465.17% | 12.63% | 97743.59% | - |
Gross Profit | 2.39 | 1.79 | 0.97 | 0.17 | 0.15 | 0 |
Selling, General & Admin | 3.68 | 3.13 | 2.42 | 1.95 | 0.25 | 0.1 |
Research & Development | 4.01 | 3.24 | 2.61 | 1.42 | 0.35 | 0.33 |
Operating Expenses | 7.92 | 6.67 | 5.74 | 4.23 | 0.64 | 0.45 |
Operating Income | -5.54 | -4.88 | -4.77 | -4.05 | -0.49 | -0.45 |
Interest Expense | - | - | - | -0 | -0.39 | -0 |
Interest & Investment Income | 0.59 | 0.74 | 0.43 | 0.04 | 0 | - |
Currency Exchange Gain (Loss) | 0.5 | -0 | 0.17 | 0.27 | 0.03 | - |
Other Non Operating Income (Expenses) | - | - | - | -1.22 | -0.06 | -0.05 |
EBT Excluding Unusual Items | -4.44 | -4.14 | -4.17 | -4.96 | -0.92 | -0.5 |
Other Unusual Items | - | - | - | -1.88 | - | - |
Pretax Income | -4.44 | -4.14 | -4.17 | -6.84 | -0.92 | -0.5 |
Income Tax Expense | - | - | - | - | - | -0.15 |
Net Income | -4.44 | -4.14 | -4.17 | -6.84 | -0.92 | -0.35 |
Net Income to Common | -4.44 | -4.14 | -4.17 | -6.84 | -0.92 | -0.35 |
Shares Outstanding (Basic) | 60 | 60 | 60 | 50 | 16 | 160 |
Shares Outstanding (Diluted) | 60 | 60 | 60 | 50 | 16 | 160 |
Shares Change (YoY) | -0.16% | - | 21.50% | 202.95% | -89.74% | - |
EPS (Basic) | -0.07 | -0.07 | -0.07 | -0.14 | -0.06 | -0.00 |
EPS (Diluted) | -0.07 | -0.07 | -0.07 | -0.14 | -0.06 | -0.00 |
Free Cash Flow | -5.39 | -4.95 | -4.26 | -3.97 | -0.85 | -0.65 |
Free Cash Flow Per Share | -0.09 | -0.08 | -0.07 | -0.08 | -0.05 | -0.00 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -231.99% | -272.37% | -491.09% | -2357.84% | -320.06% | -287538.46% |
Profit Margin | -186.12% | -231.07% | -429.62% | -3977.17% | -599.62% | -225778.20% |
Free Cash Flow Margin | -225.91% | -276.66% | -438.19% | -2309.24% | -558.77% | -416656.41% |
EBITDA | -5.53 | -4.88 | -4.77 | -4.05 | - | - |
EBITDA Margin | -231.84% | -272.27% | - | - | - | - |
D&A For EBITDA | 0 | 0 | 0 | 0 | - | - |
EBIT | -5.54 | -4.88 | -4.77 | -4.05 | -0.49 | -0.45 |
EBIT Margin | -231.99% | -272.37% | - | - | - | - |
Revenue as Reported | 2.98 | 2.53 | 1.57 | 0.49 | 0.18 | - |
Advertising Expenses | - | 0.27 | 0.09 | - | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.